TH137276A - Phytocannabinoids in cancer treatment - Google Patents
Phytocannabinoids in cancer treatmentInfo
- Publication number
- TH137276A TH137276A TH1201004672A TH1201004672A TH137276A TH 137276 A TH137276 A TH 137276A TH 1201004672 A TH1201004672 A TH 1201004672A TH 1201004672 A TH1201004672 A TH 1201004672A TH 137276 A TH137276 A TH 137276A
- Authority
- TH
- Thailand
- Prior art keywords
- cancer
- phytocannabinoids
- cancer treatment
- components
- phytocannabinoid
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 5
- 201000011510 cancer Diseases 0.000 title abstract 5
- 241000218236 Cannabis Species 0.000 claims 3
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 claims 2
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims 2
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 2
- 229950011318 cannabidiol Drugs 0.000 claims 2
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 2
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims 2
- 229960004242 dronabinol Drugs 0.000 claims 2
- 239000000284 extract Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000000419 plant extract Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 2
- 208000029742 colonic neoplasm Diseases 0.000 abstract 2
- 229940088679 drug related substance Drugs 0.000 abstract 2
- 201000001514 prostate carcinoma Diseases 0.000 abstract 2
Abstract
DC60(04/12/55) การประดิษฐ์นี้เกี่ยวกับการใช้งานของไฟโตแคนนาบินอยด์(phytocannabinoids)ทั้งใน รูปแบบที่ถูกแยกโดดเดี่ยวหรือในรูปแบบของสสารยาที่มาจากพืช(botanicaldrugsubstance (BDS))ในการรักษาของมะเร็งโดยที่พึงประสงค์มะเร็งที่จะถูกรักษาคือมะเร็งของต่อมลูกหมาก, มะเร็งของเต้านมหรือมะเร็งของโคลอน การประดิษฐ์นี้เกี่ยวกับการใช้งานของไฟโตแคนนาบินอยด์(phytocannabinoids)ทั้งใน รูปแบบที่ถูกแยกโดเดี่ยวหรือในรูปแบบของสสารยาที่มาจากพืช(botanicaldrugsubstance (BDS))ในการรักษาของมะเร็งโดยที่พึงประสงค์มะเร็งที่จะถูกรักษาคือมะเร็งของต่อมลูกหมาก, มะเร็งของเต้านมหรือมะเร็งของโคลอน DC60(04/12/55) This invention concerns the use of phytocannabinoids both in Isolated form or form of botanical drug substance (botanicaldrugsubstance) (BDS)) in the treatment of cancer, preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon. This invention concerns the use of phytocannabinoids both in Isolated form or form of botanical drug substance (botanicaldrugsubstance) (BDS)) in the treatment of cancer, preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH137276A true TH137276A (en) | 2014-10-09 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12012501782A1 (en) | Phytocannabinoids in the treatment of cancer | |
| MY156444A (en) | Anti-tumoural effects of cannabinoid combinations | |
| MX2019001286A (en) | Cannabis composition. | |
| MX381302B (en) | HYDROGENATED CANNABIS OIL. | |
| EA201200473A1 (en) | SUBSTITUTED (HETEROARILMETHYL) THIOGIDANTOINES | |
| PH12016501139B1 (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| MX2016002544A (en) | Compounds useful as immunomodulators. | |
| MX2021010033A (en) | MICROENCAPSULATED COMPOSITIONS OF CANNABINOIDS. | |
| PH12013501600A1 (en) | Novel heterocyclic derivatives | |
| MX376047B (en) | LYSINE-SPECIFIC DEMETHYLASE-1 INHIBITORS. | |
| EA201290836A1 (en) | RELATED BIS-ARYL ARYLTRIAZOLONES AND THEIR APPLICATION | |
| MX346147B (en) | 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use. | |
| MX356755B (en) | Fumigillol type compounds and methods of making and using same. | |
| MX359656B (en) | Oxoquinazolinyl-butanamide derivatives. | |
| MX376183B (en) | COMPOSITIONS FOR THE TREATMENT OF ROSACEA. | |
| ZA201708686B (en) | Nanoparticles for use as a therapeutic vaccine | |
| CO6731081A2 (en) | Method for producing and using a copolymer of sodium carboxymethylcellulose and gosipol | |
| MA32416B1 (en) | SUBSTITUTED 7-SULFANYLMETHYL-, 7-SULFINYMETHYL-AND 7-SULFONYLMETHYL-INDOLES AND THEIR USE | |
| UA117809C2 (en) | BENDAMOUSTINE DERIVATIVES, RELATED COMPOUNDS AND THEIR MEDICAL APPLICATION FOR CANCER TREATMENT | |
| TH137276A (en) | Phytocannabinoids in cancer treatment | |
| UA49514U (en) | Gel for treatment and prevention of dystrophic-inflammatory diseases of periodontium | |
| MX2020002222A (en) | Arginine deiminase encapsulated inside erythrocytes and their use in treating cancer and arginase-1 deficiency. | |
| TH126234A (en) | Mixtures to combine cannabinoids with non-cannabinoid treatment chemicals. | |
| BR112017012931A2 (en) | methods for reducing platelet aggregation and treating cardiovascular disease and other medical disorders | |
| TH124701A (en) | Antitumor effect of cannabinoid mixtures. |